Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
WBD closed at $25.28 on July 27, down 1.9% from the prior session, even as trading activity elsewhere appeared to firm.
THE APEX TIMES
THE APEX TIMES
A recent Yahoo Finance commentary framed McDonald’s ordering experience as less forgiving for customers with complicated requests, contrasting it with Starbucks’ approach that blends app control with staff execution.
THE APEX TIMES
A decline in crude benchmarks over the weekend helped weigh on ConocoPhillips stock on Monday, with investors pointing to calmer geopolitical headlines rather than company-specific news.
THE APEX TIMES
A Yahoo Finance report taking stock of the 2026 Q2 earnings calendar suggests that market expectations for Visa and Mastercard are being actively adjusted as the reporting season approaches.
THE APEX TIMES
A Yahoo Finance recap of Q1 earnings for therapeutics stocks singled out Moderna as part of an end-of-earnings-season look at which companies impressed and which faced pressure as investors reassessed pipeline and demand assumptions.
THE APEX TIMES
A lawsuit reported by Yahoo Finance puts Target in the spotlight over allegations involving Nara Organics infant formula and a confirmed infant botulism case in Washington. The filing also underscores how hard it can be to translate disputed product liability claims into a clear, market-ready valuation of exposure.
THE APEX TIMES
A Zacks.com stock screen highlighting “momentum” leaders flagged Goldman Sachs among its featured names, using a framework tied to price strength, earnings growth, and earnings-estimate performance.
THE APEX TIMES
A Yahoo Finance report linked Salesforce’s Agentforce push to rising buyer distrust around enterprise AI agents, raising the question of whether the market is discounting the technology’s long-term value or reacting to early credibility gaps.
THE APEX TIMES
An analyst note circulated by Yahoo Finance points to improving earnings indicators for CVS Health alongside peers Cardinal Health, Humana and ACADIA Pharmaceuticals, even as profitability remains under pressure in parts of the healthcare supply chain and managed care.
